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Porcine circovirus type 1 (PCV1) encodes two major ORFs. The cap gene comprises the major structural protein of PCV, the rep gene
specifies Rep and RepV, which are both essential for initiating the replication of the viral DNA. Rep corresponds to the full-length protein, whereas
RepV is a truncated splice product that is frame-shifted in its C-terminal sequence. In this study, the cellular localization of PCV1-encoded proteins
was investigated by immune fluorescence techniques using antibodies against Rep, RepV and Cap and by expression of viral proteins fused to
green and red fluorescence proteins. Rep and RepV protein co-localized in the nucleus of infected cells as well as in cells transfected with plasmids
expressing Rep and RepV fused to fluorescence proteins, but no signal was seen in the nucleoli. Rep and RepV carry three potential nuclear
localization signals in their identical N-termini, and the contribution of these motifs to nuclear import was experimentally dissected. In contrast to
the rep gene products, the localization of the Cap protein varied. While the Cap protein was restricted to the nucleoli in plasmid-transfected cells
and was also localized in the nucleoli at an early stage of PCV1 infection, it was seen in the nucleoplasm and the cytoplasm later in infection,
suggesting that a shuttling between distinct cellular compartments occurs.
D 2005 Elsevier Inc. All rights reserved.Keywords: Circoviridae; Porcine circovirus type 1 (PCV1); Nuclear localization signal (NLS); Rep protein; Cap proteinIntroduction
Porcine circoviruses (PCV) are members of the family
Circoviridae. This family comprises small icosahedral non-
enveloped viruses with a small circular single-stranded (ss)
DNA genome. Two strains of porcine circoviruses, PCV
type 1 (PCV1) and PCV type 2 (PCV2), have been
characterized. PCV1 was first identified in 1974 as a
persistent infection of the porcine kidney cell line PK-15
(Tischer et al., 1974). PCV1 does not induce a cytopatho-
genic effect in cell culture or disease symptoms in
experimentally infected animals (Tischer et al., 1986). In
contrast, PCV2 is the etiological agent of a new emerging
disease in swine, the so-called postweaning multisystemic
wasting syndrome (PMWS) (Ellis et al., 1999). The genome0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Hindenburgdamm 30, 12200 Berlin, Germany.of PCV1 consists of 1759 nucleotides (nt), while that of
PCV2 is 9 nt larger; the genomes of these two viruses
display a homology of approximately 70% (Hamel et al.,
1998). Both PCV variants display two major open reading
frames (ORF), of which the smaller ORF cap is located on
the minus strand. The Cap protein (234 amino acids, aa) is
the only structural component of the viral capsid and the
dominant immunological agent of PCV (Nawagitgul et al.,
2002). The capsid shows T = 1 symmetry rules and is built
from 12 pentamer units containing 60 subunits (Crowther et
al., 2003). The N-terminal part of Cap displays nuclear and
nucleolar localization signals, mutation of which alters the
localization of Cap (Cheung and Bolin, 2002; Liu et al.,
2001). The larger ORF rep is located on the viral plus
strand and encodes the replication proteins Rep and RepV. In
contrast to other viruses, characterized by small ssDNA
genomes, e.g. Adeno-associated virus type 2 (AAV2) and
members of the genus Mastrevirus of the family Geminivir-
idae, the replication of PCV cannot be promoted by a single
Rep protein. The full-length Rep protein (312 aa) and the
isoform RepV (168 aa) are both indispensable for viral DNA05) 36 – 46
www.e
Fig. 2. Immunological staining of Rep:8xHis and RepV:8xHis. Immunoblot of
Rep:8xHis and RepV:8xHis with a-Rep120–312 and a-RepV120–168 antisera.
(A) Crude extracts from E. coli expressing Rep:8xHis were resolved by SDS-
PAGE and analyzed by immunoblotting. Blots were incubated with a-
Rep120–312 antiserum (lane 1), a-RepV120–168 antiserum (lane 2) and
monoclonal a-HisTag antibody (lane 3). (B) RepV:8xHis was probed with a-
Rep120–312 antiserum (lane 4), a-RepV120–168 antiserum (lane 5) and
monoclonal a-HisTag antibody (lane 6). Mark 12i Wide Range Protein
Standard (lane M; molecular weight in kDa) was stained with amido black
solution.
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al., 2003). The sequence of the N-terminal 119 aa of Rep
and RepV is identical. This region contains three conserved
amino acid motifs typical for proteins mediating replication
via a rolling-circle mechanism (Koonin and Ilyina, 1992).
Additionally, the full-length Rep protein comprises a P-loop
for dNTP-binding, which is removed from the spliced RepV
protein. Introduction of point mutations into these four
conserved sequence motifs inhibits PCV1 replication (Man-
kertz and Hillenbrand, 2001). Both replication proteins bind to
double-stranded (ds) DNA fragments comprising the origin of
replication in vitro (Steinfeldt et al., 2001).
Due to the small genome size and the limited coding
capacity, it is generally acknowledged that the viral life
cycle of PCV must rely extensively on host factors. The
synthesis of viral DNA is performed during the S-phase
(Tischer et al., 1987), and replication of viral DNA is
thought to occur in the nucleus. In this report, the
localization of the PCV1-encoded proteins Rep, RepV and
Cap with and without concurrent infection was investigated.
We analyzed whether PCV-encoded proteins mutually
influence their localization and accumulate in distinct
compartments during the infection cycle. Additionally,
peptide regions were identified which mediate nuclear
translocation of Rep-EGFP fusion proteins.
Results
Generation of antisera specific for either Rep or RepV
To generate Rep- and RepV-specific antisera, the non-
homologous C-terminal sequences of Rep and RepV were
expressed as GST fusion proteins in E. coli from plasmid
pGEX:Rep120–312 and pGEX:RepV120–168 (Fig. 1). Fusion
proteins were purified from the insoluble fraction by SDS-
PAGE and used for immunization of rabbits. The resulting
antisera a-Rep120–312 and a-RepV120–168 detected the full-
length His-tagged Rep protein (40 kDa) as well as the RepV
protein (26 kDa) expressed in E. coli (Fig. 2). Cross-reaction of
Rep- and RepV-specific antisera between the two protein
isoforms was not observed in Western blot or immune
fluorescence assays (Figs. 2, 3Ai and j).Fig. 1. Genomic organization of PCV1. A linear map of the circular PCV1 genome is
replication proteins Rep and RepV are divergently transcribed; aa numbers of the N-te
protein fragments fused to GST used for immunization of rabbits are indicated.Subcellular localization of Rep, RepV and Cap in PS cells
To investigate the subcellular localization of Rep, RepV and
Cap, PS cells were infected with PCV1, and the presence of
immunoreactive proteins was detected 48 h post-infection (pi)
with a-Rep120–312, a-RepV120–168 and a-Cap104–233
(Figs. 3Aa–c). The staining with a-Rep120–312 and a-
RepV120–168 antisera indicated the nuclear localization of
both replication proteins. The fluorescence signal of Rep and
RepV was distributed irregularly within the nucleoplasm, while
no fluorescence was observed in the nucleoli. In contrast, two
distinct localization patterns of the Cap protein were observed
with the a-Cap104–233 antiserum. The signal was localized
either throughout the entire nucleus or mainly in the nucleoli
(Fig. 3Ac). When the three antisera were applied to mock-
infected control cells, no signal was detected (Figs. 3Ae–g).
The a-PCV1 antiserum, recognizing PCV1 virus particles, was
used as a positive control and showed results comparable to the
a-Cap104–233 antiserum (Fig. 3Ad).shown. The two major ORFs of PCV1 encoding the capsid protein Cap and the
rminus and the distinct C-termini of Rep and RepV are given. Rep, RepV and Cap
Fig. 3. Subcellular localization of the Rep, RepV and Cap protein in PS cells. (A) Immune fluorescence analysis of the subcellular localization of Rep, RepV and Cap
protein in PCV1-infected and transfected PS cells. Infected cells were stained with a-Rep- (a), a-RepV- (b), a-Cap- (c) or a-PCV-specific antisera (d). Mock-infected
PS cells were used as a negative control (e, f, g). PS cells transfected with plasmids pAM9 (h and i), pAM4 (j and k) or pcDNA-Cap (l) were analyzed by IFA as
described previously for infected cells. (B) Plasmids pEGFP:Rep (a), pEGFP:RepV (b) and pEGFP:Cap (c) were transfected into PS cells, and subcellular localization
of Rep, RepV and Cap EGFP fusion proteins was determined by fluorescence microscopy.
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reflect a redistribution of Cap during different phases of viral
infection. To challenge this hypothesis, the location of PCV1-
encoded proteins was tested after expression of cloned Cap,
Rep and RepV, that is, proteins were expressed not in the
context of a PCV1 infection. Plasmids pAM4 (RepV protein),
pAM9 (Rep protein) and pSVLCap(PCV1) (Cap protein) were
transfected into PS cells, and localization was analyzed by IFA
using the corresponding antiserum. In addition, plasmids
expressing Rep, RepV and Cap fused to EGFP or RFP were
used in parallel experiments. At 48 h post-transfection (pt),
cells were fixed and analyzed by confocal laser scanning
microscopy. Rep and RepV (Figs. 3Ah and k) as well as the
EGFP variants EGFP:Rep and EGFP:RepV (Figs. 3Ba and b)
were localized exclusively in the nucleoplasm. In contrast to
the results observed after PCV1 infection, the isolated Cap
protein and the EGFP:Cap fusion protein were seen only in the
nucleoli of transfected cells, but not in the nucleoplasm (Figs.
3Al and Bc).
The nucleolar localization of Cap was further investigated
by immunostaining of the nucleoli using a mouse a-human
nucleoli monoclonal antibody (Chemicon). This human anti-
body did not detect the nucleoli in porcine PS cells (data not
shown). Therefore, the human 293 cell line was transfected
with plasmid pEGFP:Cap. Cells were fixed 48 h pt and
analyzed by confocal laser scanning microscopy after staining
with the nucleoli-specific antibody (Figs. 4a–c). The observed
localization pattern of EGFP:Cap in transfected 293 cells was
comparable to the results obtained in PS cells. The merged
signals showed that Cap was co-located with the nucleolar
staining of the a-nucleoli monoclonal antibody (Fig. 4c).
To investigate the localization of viral proteins with respect
to each other, double staining was performed. Analysis of Rep
plus RepV in PCV1-infected PS cells showed nuclear localiza-
tion with the exception of the nucleoli for both proteins (Figs.
5a and b), the merge of both signals indicated co-localization of
Rep and RepV (Fig. 5c). Similar results were obtained after co-
expression of EGFP:Rep and RFP:RepV (Figs. 5l–n).
Analysis of Cap plus Rep in infected cells showed variable
results. The Cap protein was either localized spatially separated
from the Rep protein in the nucleoli (Figs. 5d–f) or co-localized
with the Rep protein in the nucleoplasm (Figs. 5g–i). This
effect was not observed in PS cells co-expressing RFP:Cap with
EGFP:Rep and EGFP:RepV from plasmids pDSRed:cap andFig. 4. The EGFP:Cap fusion protein is localized in the nucleoli of transfected 293 ce
mouse a-human nucleoli monoclonal antibody and subsequently analyzed by confo
while panel b shows the stained nucleoli. The overlay of both channel signals is shpEGFP:rep. The RFP:Cap fusion protein was localized in the
nucleoli, while Rep and RepV fusion proteins were located
separately in the nucleoplasm (Figs. 5o–q). Two negative
controls have been performed to demonstrate the specificity of
the double staining reaction. When rabbit a-Cap and a-Rep
antisera were saturated with an excess of the Fab fragment of
goat a-rabbit IgG (Fig. 5j), no signals were obtained with Cy5-
conjugated donkey a-rabbit IgG. When the infected cells were
incubated with rabbit a-Cap and a-Rep antisera and afterwards
probed with Cy3-conjugated donkey a-goat IgG, no fluores-
cence was seen (Fig. 5k). In summary, these results indicate that
the localization of Cap is not influenced by the expression of the
Rep and RepV fusion proteins.
Localization of Cap at different time points after infection
To define whether the two distinct localization patterns of
Cap in infected cells can be correlated to the kinetics of an
infection, we analyzed the localization of Cap in PCV1-
infected PS cells at different time points after infection by
IFA with a-Cap104–233 antiserum (Figs. 6a–f). The protein
localization was screened at 4 h, 12 h, 16 h, 24 h and 48 h pi.
At 4 h pi, only weak fluorescence signals were detected in the
cytoplasm by Cap-specific antiserum (Fig. 6b), representing
either newly synthesized or internalized Cap protein as
recently described for PCV-like particles (Misinzo et al.,
2005). At 12 h and 16 h pi, the Cap protein was located
mostly in the nucleoli of infected cells (Figs. 6c and d), while
redistribution to the nucleoplasm was seen at 24 h pi (Fig.
6e). At 48 h pi, Cap was localized in the nucleoplasm in the
majority of the infected cells but also occasionally in the
cytoplasm, whereas almost no Cap-specific signal was
observed in the nucleoli (Fig. 6f). Since no alteration of
Cap localization was seen after co-transfection of Rep and
Cap EGFP fusion proteins, this suggests that the change of
subnuclear localization may coincide with the viral DNA
replication or virion assembly.
To obtain further information about Cap redistribution,
Cap:EGFP fusion protein was expressed by the recombinant
PCV1 strain RVC2. Localization of Cap:EGFP in living cells
was determined at 24 and 36 h pt. At 24 h pt, the majority of
cells showed Cap:EGFP in the nucleoli, whereas redistribution
of EGFP:Cap to the nucleoplasm was seen in the very same
cells at 32 h pt (Figs. 6g and h).lls. 293 cells were fixed 48 h after transfection with pEGFP:Cap, stained with a
cal laser scanning microscopy. The signals of EGFP:Cap are given in panel a,
own in panel c.
Fig. 5. Co-localization of Rep, RepV and Cap in PCV1-infected and non-infected PS cells. Double staining of Rep and RepV 48 h pi, using a-Rep- (a) and a-RepV-
specific antisera (b), is shown. The merge of both signals is given in panel c. Double staining of the Cap and Rep protein 48 h pi is shown in two exemplary
views. Cap and Rep were detected using a-Cap- (d and g) and a-Rep-specific antisera (e and h). The merged signals are shown in panels f and i. Specificity of
the double staining reaction is demonstrated by two negative controls (j and k). Constructs pEGFP:Rep and pDsRed:RepV, expressing the two rep gene products
fused to the green or red fluorescent protein, as well as pEGFP:rep (expressing EGFP:Rep and EGFP:RepV) and pDsRed:Cap were co-transfected into PS cells
and subsequently analyzed by confocal laser scanning microscopy. For detection of RFP:RepV (l) or RFP:Cap (o), excitation at 543 nm was used, for detection of
EGFP:Rep (m) or EGFP:Rep/EGFP:RepV (p), excitation was performed at 488 nm with the appropriate emission filter sets. The overlay of both channel signals is
shown in panels n and q.
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The Rep and RepV proteins are localized in the nucleus of
PCV1-infected PS cells as well as in non-infected PS cells
transfected by cloned Rep and RepV. This indicates that the
nuclear import of the rep gene proteins is independent of other
viral proteins and that the process might be directed by a nuclear
localization signal (NLS). Examination of the aa sequence ofRep and RepV revealed that their common N-terminus contains
three clusters of basic aa with homology to other NLS, which
we have termed NLS1 (12KRWVFTLNNPSEEEKNKIR-
ELP33; bold letters indicate basic aa), NLS2 (63KKQTFNKVK-
WYFGARCHIEKAKGTD87) and NLS3 (107PRNQGKRQ
SDL116). In NLS1, two boxes of basic aa are separated by a
spacer sequence of 12 aa, corresponding to the consensus motif
of a bipartite NLS (Dingwall and Laskey, 1991). NLS2 is also
Fig. 6. Subcellular localization of Cap at different time points after infection. PS cells were infected with PCV1 and analyzed by IFAwith a-Cap-specific antiserum at
4 h, 12 h, 16 h, 24 h and 48 h pi (b, c, d, e and f). Non-infected PS cells were used as a negative control (a). Living PS cells transfected with RVC2 were analyzed at
24 h and 32 h pt (g and h) by fluorescence microscopy.
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consensus motifs. NLS3 shows homology to the c-Myc NLS
with only three basic residues in a cluster of nine aa (Dang and
Lee, 1989; Makkerh et al., 1996). To determine whether these
putative NLS are involved in nuclear import of Rep and RepV,
truncated or mutated fragments of Rep were fused to EGFP
(Fig. 7). The resultant constructs were transfected into PS cells,
and the localization of the fusion proteins was analyzed.
Nuclear localization of the fusion protein EGFP:Rep1–119
reveals that the N-terminal fragment containing NLS1, NLS2
and NLS3 is sufficient to mediate the nuclear import of Rep
(Fig. 8h). When this fragment was truncated at the C-terminus,
a predominant nuclear localization was seen for the EGF-
P:Rep1–88 and EGFP:Rep1–106 fusion proteins (Figs. 8f and
g), while distribution throughout the entire cell was observed
for the EGFP:Rep1–50 and EGFP:Rep1–73 fusion proteins
(Figs. 8d and e), comparable to EGFP (Fig. 8a). This indicates
that NLS2 and 3 are required for nuclear localization of Rep
and RepV.
Next, the Rep protein was truncated at the N-terminus.
Deletion of the first two aa of NLS1 (pEGFP:Rep14–312,
Fig. 8b) did not change nuclear accumulation compared to
wt-Rep fused to EGFP. In contrast, complete removal of
NLS1 (pEGFP:Rep30–312, Fig. 8c) directed the fusion
protein to the cytoplasm. This demonstrates that aa 14 to
29 of NLS1 are essential for nuclear localization of Rep and
that NLS2 plus NLS3 are unable to traffic the truncated
protein to the nucleus.To define the contribution of each NLS for nuclear
localization, we mutated NLS1, 2 and 3. Mutagenesis of two
basic aa in NLS1 (pEGFP:Rep-mutNLS1, Fig. 8i) or of six
basic aa in NLS2 (pEGFP:Rep-mutNLS2, Fig. 8j) abolished
nuclear localization of the fusion proteins, while exchange of
two basic aa in NLS3 (pEGFP:Rep-mutNLS3, Fig. 8k) did not
interfere with nuclear accumulation of the protein. These
experiments signify that NLS1 and NLS2 are required to
mediate the nuclear import, while NLS3 merely enhances the
nuclear import of Rep. Similar experiments have been
performed with the RepV protein and gave analogous results
(data not shown).
Discussion
The nucleus of mammalian cells is organized in several
subcompartments including the nucleoli, nuclear speckles,
transcription and replication foci and chromosome territories
(Lamond and Earnshaw, 1998). Since knowledge about the site
of replication and maturation of PCV is rather scant,
investigation of the subnuclear localization of PCV-encoded
proteins will provide additional information to understand
these processes.
In this study, we have investigated the localization of the
PCV1-encoded proteins Rep, RepV and Cap. Visualization was
either achieved by antisera detecting Rep, RepV and Cap or with
fluorescence tags fused to the viral proteins. Using IFA,
expression of the full-length Rep protein and the spliced RepV
Fig. 7. Map of the EGFP:Rep constructs. (A) A sketch of the rep gene indicating putative NLS motifs by shaded boxes is given. Below, the truncated or mutated
fragments of the rep gene used to produce EGFP fusion proteins are shown. C or N indicates cytoplasmatic or nuclear localization of the resultant EGFP fusion
proteins. (B) The aa sequence of the N-terminal part of the Rep protein (1–119 aa) (basic aa in bold) and the aa sequence of the mutated NLS motifs are listed.
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Rep and RepVwere co-localized in the nucleus, but never in the
nucleoli, regardless whether the expression was due to
infection or cloned proteins. Alteration in localization during
the infection cycle was not seen. Accumulation of Rep and
RepV in defined subnuclear regions as described for other DNA
viruses, e.g. the replication compartments of herpes viruses
(Quinlan et al., 1984), has not been observed.
Nuclear localization of Cap in infected cells and NLS
sequences in the N-terminal part of Cap of PCV1 and PCV2
has been described earlier (Cheung and Bolin, 2002; Liu et al.,
2001). We analyzed the localization of Cap with respect to the
infection status of the cells and the presence of the replication
proteins Rep and RepV. EGFP- or RFP-tagged Cap protein was
seen in the nucleoli, while IFA of PCV1-infected cells revealed
two distinct distribution patterns of the Cap protein. During
infection, Cap was either found to reside in the nucleoli or to
co-localize with the replication proteins in the nucleoplasm of
PCV1-infected cells. Kinetic analysis of the subcellular
localization of Cap demonstrated that localization to the
nucleoli during early infection was followed by redistribution
to the nucleoplasm.Since Rep, RepV and Cap are all located in the nucleoplasm,
this indicates that DNA replication and encapsidation of the
circular closed ssDNA occur in the nucleus and not in
cytoplasmic compartments. The biological function of the
early localization of Cap to the nucleoli remains unclear.
Nucleolar localization has been described for proteins of many
DNA and RNAviruses (Hiscox, 2002). It is proposed that virus
proteins enter the nucleoli to support viral transcription or alter
the cell cycle. It will be interesting to learn whether the PCV1-
encoded proteins interact with cellular factors regulating
transcription and cell cycle. Analysis of the interaction of viral
proteins with cellular factors is currently being carried out.
Since co-expression of the viral proteins showed no effect
on their mutual localization, the twofold localization pattern of
Cap is probably not influenced by the Rep and RepV protein.
Furthermore, since translocation of both replication proteins to
the nucleus is independent of other viral factors, the trafficking
of Rep and RepV to the nucleus should be regulated by an
intramolecular NLS. Three stretches of positively charged aa in
the N-terminus of the PCV1 Rep protein show homology to an
NLS. NLS1 shows homology to the consensus sequence of the
bipartite NLS type (Dingwall and Laskey, 1991), whereas
Fig. 8. Mapping of the NLS of Rep and RepV. PS cells were transfected with plasmids carrying mutated and truncated versions of the rep gene to analyze their
subcellular location. The following plasmids were used: pEGFP-C2 (a), pEGFP:Rep14–312 (b), pEGFP:Rep30–312 (c), pEGFP:Rep1–50 (d), pEGFP:Rep1–73
(e), pEGFP:Rep1–88 (f), pEGFP:Rep1–106 (g), pEGFP:Rep1–119 (h), pEGFP:Rep-mutNLS1 (i), pEGFP:Rep-mutNLS2 (j) and pEGFP:Rep-mutNLS3 (k).
Localization of EGFP fusion proteins was determined by confocal laser scanning fluorescence microscopy 48 h pt.
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positively charged aa flanked by Pro and Asp and is thereby
similar to the NLS sequences of the c-Myc protein (Dang and
Lee, 1989). To characterize the role of these three NLS
sequence, truncated and mutated rep gene variants were fused
to EGFP. The fragment aa 14–119 was found to be sufficient
for mediating nuclear import of EGFP. Deletion of the first two
aa (K12 and R13) of NLS1 had no impact on Rep localization,
signifying that they are not essential for nuclear import,
whereas aa 14–29 within NLS1 were shown to be indispens-
able. Shortening of the fragment from the C-terminus from aa
119 to 106 or 119 to 88 provided evidence that NLS3 enhances
nuclear import. The results of three rep gene variants mutated
in their NLS demonstrated that NLS1 and NLS2 but not NLS3
are essential for nuclear localization. These experiments
indicate that the right part of NLS1 and NLS2 are required to
mediate the nuclear import, whereas NLS3 enhances the
nuclear accumulation of the replication proteins.
The observed subcellular localization patterns of viral
proteins led us to propose the following working hypothesis:
the Cap protein enters the nucleoli in the beginning of
infection, this may be linked to arrest of the cells in the S-
phase and modification of host protein production. During the
infection cycle, the viral proteins Cap, Rep and RepV
accumulate in the nucleoplasm, where viral replication, capsid
formation and encapsidation take place. Finally, the capsidassembly in the nucleus is a prerequisite for translocation to the
cytoplasm and subsequent release of mature virions. This
hypothesis is currently under investigation.
Materials and methods
Plasmids
Plasmids pORF4A, pAM4, pAM9 and pSVLCap(PCV1),
expressing genes under control of the SV40 late promoter, are
based on vector pSVL (Amersham Biosciences, Freiburg).
pORF4A (Mankertz et al., 1998) encodes the wild-type (wt)
rep gene of PCV1 (GenBank accession number: Y09921),
while pAM9 and pAM4 carry only one of the two Rep
proteins: pAM9 encodes the rep gene mutated in several splice
donor sites, thereby disabling synthesis of RepV, pAM4 carries
the cDNA product of the repV transcript (Mankertz and
Hillenbrand, 2001). Plasmid pSVLCap(PCV1) was used for
expression of Cap (Mankertz and Hillenbrand, 2002). Expres-
sion vectors pEGFP-C2, pDsRed1-C1 (BD Biosciences Clon-
tech, Heidelberg), pGEX-6P-1 (Amersham Biosciences) or
pTriEx-1.1 (Merck Biosciences, Bad Soden) were used for
expression of Rep, RepV, Cap and truncation mutants fused to
EGFP (enhanced green fluorescent protein), RFP (red fluores-
cent protein), GST (glutathione S-transferase) or an 8xHis-tag.
DNA fragments were amplified via PCR using the High
Table 1
Oligonucleotides
Name Oligonucleotide sequence in 5V–3V direction Restriction site
F137 GAAGATCTATGGTGAGCAAGGGCGAGGAGCTGT BglII
F141 CGGGATCCATTTTTATTTATTTAGAGGGTCTTTTAGGA BamHI
F209 CCGCTCGAGTTATTTATTTAGAGGGTCTTTTAGGATAAA XhoI
F225 CGGGATCCCCAAGCAAGAAAAGCGGCCCG BamHI
F245 CGGGATCCAAGCAAGAAAAGCGGC BamHI
F273 GGAATTCTCCAAGCAAGAAAAGCGGC EcoRI
F312 GGGGATCCGTGAGTACCCTTTTGGAGACGGGG BamHI
F313 GGGGATCCTATTTTGATTACCAGCAATCAGGC BamHI
F511 CGGAATTCATGCCAAGCAAGAAAAGC EcoRI
F514 CGGAATTCCGGGAGCTTCCAATCTCCC EcoRI
F518 CGGAATTCTGGGTGTTCACCCTTAATAATCC EcoRI
B519 CGGGATCCACCCTCTTCCAAACCTTCCTC BamHI
F636 GCAGTTAACGTTATAGGGGAGCTTCCAATCTCCCT AclI
F638 TTCGCGGGCGCCAAAGGAACCGACCAGCAG NarI
F640 TCAGACTTTTAACGCGGTGGCTTGGTATTTTGGTGCCGCGTGCCACATCGAGGG
F642 GAGCGGCGCCGCTAGCGACCTGTCTACTGCTG HaeII
B138 GAAGATCTTACTTGTACAGCTCGTCCATGCCG BglII
B142 CCGCTCGAGGATGACGTGGCCAAGGAGGC XhoI
B148 TATGACCATGATTACGCCAAGCTT
B167 CGGGATCCTTACGATGTGATAACAAAAAAGACTCAGT BamHI
B210 CGGGATCCTATGAATTTTACCCCAGAGACCC BamHI
B226 GGAATTCGATGTGATAACAAAAAAGACTCAGT EcoRI
B273 GGAATTCTACGTGGCCAAGGAGGCGTTAC EcoRI
B289 GGCGCGCCCAGTAATTTATTTTATATGGG AscI
B290 GGCGCGCCCAAATCGGCCTTCGGGTACC AscI
B512 CGGGATCCAGCAGTAGACAGGTCGCTG BamHI
B520 CGGGATCCATACCACTTCACCTTG BamHI
B521 CGGGATCCCTGGTCGGTTCCTTTCGC BamHI
B637 CCAGTTAACGTTTTTCTCCTCCTCGGAAGG AclI
B639 CGCTATAGCGCTAGCAAAATTAGCAAACCC HaeII
B641 CGCCCTCGATGTGGCACGCGGCACCAAAATACCAAGCCACCGCGTTAAAAGTCTGAGCGC
B643 ACAAGGGCGCCCTGGTTCCGCGGAGCTC HaeII
B715 GCGGATCCAGCTCCACACTCGATAAG BamHI
150mut BglII TTTTTATTTAGATCTATTTAGAGGGTCTT BglII
A147 GGTGGTGGGACTCGGACTGCTTCACTGTAAAACGACGGCCAGTGAATTC
A147tag GGTGGTGGGACTCGGACTGCTTCAC
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tagged primers (Table 1). Cycling parameters were 94 -C, 2
min, 30{94 -C, 15 s; 60 -C, 30 s; 72 -C, 45 s}, 72 -C, 7 min.
PCR products were inserted via the newly introduced
restriction sites into suitable plasmids and sequenced to
exclude PCR-acquired nucleotide misincorporation. All clon-
ing steps were performed according to standard techniques
(Sambrook and Russell, 2001).
(a) Primer pairs and templates for amplification of rep-
specific PCR products cloned into pEGFP-C2 or pDsRed1-C1
are listed: construct pEGFP:rep, primer pair F511-B167,
template pORF4A; pEGFP:Rep, F511-B167, pAM9;
pEGFP:RepV, F511-B167, pAM4; pEGFP:Rep14–312, F518-
B167, pAM9; pEGFP:Rep30–312, F514-B167, pAM9; pEGF-
P:Rep1–50, F511-B519, pORF4A; pEGFP:Rep1–73, F511-
B520, pORF4A; pEGFP:Rep1–88, F511-B521, pORF4A;
pEGFP:Rep1–106, F511-B715; pEGFP:Rep1–119, F511-
B512, pORF4A; pEGFP:Rep14–119, F518-B512, pORF4A;
pDsRed:RepV, F273-B167, pAM4. For introducing base altera-
tions within the rep gene, template pORF4A and mutagenesis
primer sets were used. For construction of pEGFP-mutNLS1,
PCR products of F511-B637 and F636-B167 were ligated viathe introduced AclI restriction site. For construction of pEGFP-
mutNLS2, PCR products of F511-B639 and F638-B167 were
ligated with the hybridization product of F640 and B641 using
HaeII and NarI sites. For construction of pEGFP-mutNLS3,
PCR products F511-B643 and F642-B167 were ligated via the
introduced HaeII restriction sites. All ligation products were
inserted into pEGFP-C2 via BamHI and EcoRI sites. (b) For
cloning of rep-specific fragments into pGEX-6P-1, the primer
pairs and templates for the PCR reaction are given: pGEX:-
Rep120–312, F312-B226, pORF4A; pGEX:RepV120–168,
F313-B226, pORF4A. (c) For construction of pTriEx:Rep
primer pair, F245-B289 and template pORF4A were used,
and, for construction of pTriEx:RepV primer pair, F245-B290
and template pAM4 were used. (d) For cloning the cap gene
into pEGFP-C2 or pDsRed1-C1, the following primer pairs and
templates were used for the PCR reactions: pEGFP:Cap, F141-
B142, pSVLCap(PCV1); pDsRed:Cap, F141-B273,
pSVLCap(PCV1). (e) For cloning the cap-specific fragment
into pGEX-6P-1, the primer pair F209-B210 and the template
pSVLCap(PCV1) were used for the PCR reaction to produce
pGEX:Cap(104–233). (f) Plasmid pSK144 (pUC8 carrying the
complete PCV1 genome cloned at the single PstI site) was used
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BglII site was introduced at the 3V-end of the cap gene by site-
directed mutagenesis (Stappert et al., 1992). Plasmid pSK144
was used as template with oligonucleotides 150mut BglII and
A147. B148 and A147 tags were used for amplification in the
second mutagenesis step. The egfp gene was subsequently fused
to the cap gene via the BglII restriction site. For amplification of
the egfp gene, BglII restriction site containing oligonucleotides
F137 and B138 was used with pEGFP-C2 as template. For
transfection of PS cells with DNA of the recombinant or wt
virus, plasmid pRVC2 or pSK144 was digested with PstI. The
linearized genomic fragment was purified by agarose gel
electrophoresis and subsequent gel extraction using the QIA-
quick gel extraction kit (Qiagen, Hilden). The genomic
fragment was religated and purified with the QIAquick PCR
purification kit (Qiagen) prior to transfection.
Generation of a-Rep(120–312), a-RepV(120–168) and
a-Cap(104–233) antisera
To generate antisera specific for Rep or RepV, the C-
terminal 193 aa of Rep, as well as the C-terminal 49 aa of
RepV were fused to glutathione S-transferase (GST). Resultant
plasmids pGEX:Rep120–312 and pGEX:RepV120–168 were
transformed into E. coli BL21 (Amersham Biosciences). After
expression, the fusion proteins were purified from the
insoluble fraction by excision of protein bands after SDS-
PAGE. Transformation and protein amplification were done
according to the recommendations of the manufacturer
(Amersham Biosciences). Rabbits were immunized with
70–90 Ag of the purified protein (BioGenes, Berlin) accord-
ing to standard procedures. Immunization was repeated four
times in 3-week intervals. The serum was absorbed with PS
cells and E. coli according to published protocols (Lane and
Harlow, 1982). In a parallel procedure, the C-terminus of the
Cap protein was expressed as a GST fusion protein from
plasmid pGEX:Cap104–233 and used for generation of an a-
Cap104–233 antiserum.
Immunoblot analysis
SDS-PAGE and immunoblotting were performed to test
the specificity of the a-Rep120–312 and a-RepV120–168
antisera. Rep and RepV were expressed as 8xHis-tagged
proteins from pTriEx:Rep or pTriEx:RepV in E. coli, strain
Tuneri(DE3)placI (Merck Biosciences). Bacteria trans-
formed with the expression plasmids were grown at 33 -C
in LB to 0.8 OD588, and protein expression was induced with
0.1 mM IPTG for 2 h. E. coli cell extracts containing His-
tagged Rep and RepV proteins were analyzed in Western blots
(Sambrook and Russell, 2001). After SDS-PAGE, proteins
were blotted onto Immobilon PVDF membranes (Millipore,
Schwalbach). The membranes were blocked with 3% BSA in
10 mM Tris–HCl pH 7.5, 100 mM NaCl and 0.05% Tween
20 for 1 h at room temperature and probed with polyclonal
rabbit a-Rep120–312 antiserum (1:400), a-RepV120–168
antiserum (1:400) or a-HisTag antibody (1:5000; Dianova,Hamburg) for 1 h at room temperature. The membranes were
washed and treated with a 1:5000 dilution of alkaline-
phosphatase-conjugated goat a-rabbit IgG or goat a-mouse
IgG antibody. Detection was performed with the multicolor
detection set (Merck Biosciences). The molecular weight
marker Mark 12i Wide Range Protein Standard (Invitrogen,
Karlsruhe) was visualized with amido black solution (Towbin
et al., 1979).
Cells and virus
PS cells free of PCV are derived from PK-15 cells (ATCC
CCL33; American Type Culture Collection, Rockville, MD)
and were propagated in DMEM with 5% fetal calf serum at
37 -C and 5% CO2. PCV1 stocks were isolated from PS cells
transfected with the religated PCV1 genome. Four days pt,
cultures were frozen and thawed three times. Cell debris was
removed from infectious supernatants by low-speed centrifu-
gation. Ultracentrifugation followed for 6 h at 66,000  g in
a SW28 rotor. The titer of the resultant stock of PCV1 was
determined by incubation of PS cells with serial 10-fold
dilutions and immunocytochemical staining after three days to
be 105 TCID50 ml
1. This stock was used for all infection
experiments.
Fluorescence and indirect immune fluorescence microscopy
PS cells or 293 cells were seeded on glass coverslips in 48-
well plates and grown for 24 h in DMEM supplemented with
5% fetal calf serum at 37 -C in 5% CO2. All transfections were
performed with Effectene transfection reagent (Qiagen) using
150 ng of plasmid DNA. For fluorescence microscopy, 70–
80% confluent cells were transfected with the recombinant
PCV1 strain RCV2, the pEGFP-C2 or the pDsRed1-C1-based
constructs described in this study. For analysis in a Zeiss
LSM510 confocal microscope, cells were fixed with 4%
formaldehyde in PBS and washed. The coverslips were
mounted in Immu-Mount (Shandon, Frankfurt). For depiction
of EGFP fusion proteins, samples were investigated at 488 nm
with the appropriate emission filter sets, while for imaging of
DsRed (RFP) fusion proteins, 543 nm was used.
For the indirect immune fluorescence assay (IFA), 70–80%
confluent cells on coverslips were transfected with 150 ng of
plasmid DNA or infected with PCV1 (105 TCID50 ml
1) at a
multiplicity of infection of 101 per cell. Higher virus
concentration did not improve infection rate of PS cells
(Hattermann et al., 2004). Cells were fixed and permeabilized
by immersing the coverslips in 20 -C methanol/acetone (1:1)
for 10 min and subsequently air-dried. Cells were blocked for 1
h with 1% BSA and 0.05% Tween 20 in PBS and stained with
the primary a-Rep120–312 antiserum, 1:300; a-RepV120–168
antiserum, 1:300; a-Cap104–233 antiserum, 1:300; a-PCV1
antiserum, 1:300 (kindly provided by Dr. I. Tischer, Robert
Koch-Institut, Berlin); or mouse anti-human nucleoli mono-
clonal antibody, 1:30 (Chemicon International), diluted in
blocking buffer for 2 h at room temperature. The cells were
washed three times with PBS plus 0.05% Tween 20 and
T. Finsterbusch et al. / Virology 343 (2005) 36–4646incubated with FITC-conjugated goat a-rabbit IgG (Dianova,
Hamburg) or rhodamine red-conjugated goat a-mouse IgG
(Dianova). Subsequently, the coverslips were washed, mounted
and analyzed by confocal laser scanning microscopy.
For double staining (Negoescu et al., 1994) of Rep and
RepV, Rep was detected with the rabbit a-Rep120–312
antiserum, which was labeled afterwards with excess Fab
fragment of goat a-rabbit IgG, 1:100 (Dianova), and visualized
with Cy3-conjugated donkey a-goat IgG antibody, 1:400
(Dianova). Cy5-conjugated donkey a-rabbit IgG antibody,
1:400 (Dianova), was used in addition to the rabbit a-
RepV120–168 antiserum to detect RepV. For double staining
assay of Cap and Rep, Cap was detected with the rabbit a-
Cap104–233 antiserum in conjunction with the Fab fragment
of goat a-rabbit IgG and the Cy3-conjugated donkey a-goat
IgG antibody. Detection of Rep was performed with a-
Rep120–312 rabbit antiserum and Cy5-conjugated donkey a-
rabbit IgG antibody. Cy5 was excited with a He–Ne laser at a
wavelength of 633 nm and detected using a 665 nm long-pass
filter. Cy3 was excited at 543 nm with an external He–Ne laser
and detected using a 575–600 nm band pass filter.
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